Stylus will use the Eli Lilly and J&J-backed funds to advance its in vivo genetic medicines platform and develop its pipeline ...

Realta Fusion, a spin-off from the University of Wisconsin, is hopeful that it will crack the fusion energy puzzle with its ...

Cambridge, USA-based biotech Stylus Medicine, which says it is dedicated to developing transformative in vivo genetic ...

Stylus Medicine is unsheathing, penning a mission to develop next-gen in vivo genetic medicines with $85 million in hand, ...

The numbers for the most-active startup investors in the U.S. certainly bear that out, as Andreessen Horowitz and Khosla ...

Former Palantir Technologies Inc. adviser Jacob Helberg plans to retain investments in dozens of artificial intelligence, ...

At just 21 years old, Ethan Thornton is rewriting the rules of modern warfare. He's the founder and CEO of Mach Industries, a ...

Somite AI, a TechBio company leveraging foundation models and proprietary AI to accelerate human cell therapy development, closed its Series A funding round, raising more than $47 million. The round ...

Investors have reaped billions of dollars in gains from backing database software firms Snowflake and Databricks. Now venture ...

Tech titans and DC policymakers sound the alarm on China's AI and defense tech surge at the high-powered Hill and Valley ...

NewLimit, a startup that aims to increase how long people can live a healthy life by genetically programming their cells, has ...